Commit to a comprehensive, financed national plan with accountability and civil society engagement. A master plan to combat antimicrobial resistance.
Why is it essential? Challenges to overcome The role of government
Strengthen surveillance and laboratory capacity
Why is it necessary? Challenges to overcome Core actions
Ensure uninterrupted access to essential medicines of assured quality
Why is it necessary? Challenges to overcome Core Actions
Regulate and promote rational use of medicines, including in animal husbandry, and ensure proper patient care.
Reduce use of antimicrobials in food-producing animals.
Why address it? Challenges to overcome Examples
Enhance infection prevention and control (IPC).
Why are prevention and control of infections essential? Challenges to overcome Core Actions Selected IPC practices for prevention of emergence and spread of antimicrobial-resistant organisms
Foster innovations and research and development for new tools.
Why are more research and new product development essential? Challenges to overcome Core Actions The antimicrobial research and development pipeline
PAHO/WHO Campaign
Combat Drug Resistance: No action today, no cure tomorrow
14-20 November, 2011 Webinars | Colloquium
18 November, 2011
European Centre for Disease Prevention and Control
14-20 November, 2011 Centers for Disease Prevention and Control
South American Infectious Diseases Initiative
Regional Office for the Americas of the World Health Organization 525 Twenty-third Street, N.W., Washington, D.C. 20037, United States of America Tel.: +1 (202) 974-3000 Fax: +1 (202) 974-3663